Examining multiple funding flows to public healthcare providers in low- and middle-income countries - results from case studies in Burkina Faso, Kenya, Morocco, Nigeria, Tunisia and Vietnam.

Multiple funding flows healthcare financing healthcare provider behaviour strategic purchasing universal health coverage

Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
28 Nov 2023
Historique:
received: 18 07 2022
revised: 25 04 2023
accepted: 07 11 2023
medline: 29 11 2023
pubmed: 17 11 2023
entrez: 16 11 2023
Statut: ppublish

Résumé

Provider payment methods are traditionally examined by appraising the incentive signals inherent in individual payment mechanisms. However, mixed payment arrangements, which result in multiple funding flows from purchasers to providers, could be better understood by applying a systems approach that assesses the combined effects of multiple payment streams on healthcare providers. Guided by the framework developed by Barasa et al. (2021) (Barasa E, Mathauer I, Kabia E et al. 2021. How do healthcare providers respond to multiple funding flows? A conceptual framework and options to align them. Health Policy and Planning  36: 861-8.), this paper synthesizes the findings from six country case studies that examined multiple funding flows and describes the potential effect of multiple payment streams on healthcare provider behaviour in low- and middle-income countries. The qualitative findings from this study reveal the extent of undesirable provider behaviour occurring due to the receipt of multiple funding flows and explain how certain characteristics of funding flows can drive the occurrence of undesirable behaviours. Service and resource shifting occurred in most of the study countries; however, the occurrence of cost shifting was less evident. The perceived adequacy of payment rates was found to be the strongest driver of provider behaviour in the countries examined. The study results indicate that undesirable provider behaviours can have negative impacts on efficiency, equity and quality in healthcare service provision. Further empirical studies are required to add to the evidence on this link. In addition, future research could explore how governance arrangements can be used to coordinate multiple funding flows, mitigate unfavourable consequences and identify issues associated with the implementation of relevant governance measures.

Identifiants

pubmed: 37971183
pii: 7424416
doi: 10.1093/heapol/czad072
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1139-1153

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© World Health Organization, 2023. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article.

Auteurs

Fahdi Dkhimi (F)

Department of Health Systems Governance and Financing, World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.

Ayako Honda (A)

Research Centre for Health Policy and Economics, Hitotsubashi Institute for Advanced Study, Hitotsubashi University, 2-1 Naka Kunitachi, Tokyo 186-8601, Japan.

Kara Hanson (K)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, United Kingdom.

Rahab Mbau (R)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, PO Box 43640-00100, Nairobi, Kenya.

Obinna Onwujekwe (O)

Health Policy Research Group, College of Medicine, University of Nigeria, Enugu Campus, Enugu 400001, Nigeria.

Hoang Thi Phuong (HT)

Health Strategy and Policy Institute, Ministry of Health, 196 Alley, Ho Tung Mau, Cau Giay, Hanoi 100000, Vietnam.

Inke Mathauer (I)

Department of Health Systems Governance and Financing, World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.

El Houcine Akhnif (EH)

Morocco Country Office, World Health Organization, N3 Avenue Prince Sidi Mohamed, Suissi, Rabat 10000, Morocco.

Imen Jaouadi (I)

École Supérieure de Commerce de Tunis, Université de la Manouba, Tunis, Manouba 2010, Tunisia.

Joël Arthur Kiendrébéogo (JA)

Health Sciences Training and Research Unit, Department of Public Health, University Joseph Ki-Zerbo, 04 BP 8398, Ouagadougou 04, Burkina Faso.

Nkoli Ezumah (N)

Health Policy Research Group, College of Medicine, University of Nigeria, Enugu Campus, Enugu 400001, Nigeria.

Evelyn Kabia (E)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, PO Box 43640-00100, Nairobi, Kenya.

Edwine Barasa (E)

Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford 01540, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH